Amyloid pathology modulates the relationship between subsyndromal symptomatic depression and tau accumulation in non-demented older adults
These findings suggest that SSD is associated with greater early tau accumulation in individuals with Aβ pathology.
Authors
- Hongchun Wei
- Min Kong (ORCID: https://orcid.org/0000-0002-4884-6991)
- Yanhong Tai (ORCID: https://orcid.org/0000-0001-8818-6716)
- Jiahe Bai (ORCID: https://orcid.org/0009-0000-2424-3136)
- Xiaonan Wei
- Maowen Ba (ORCID: https://orcid.org/0000-0003-0621-5558)
- Chunhua Zhang (ORCID: https://orcid.org/0009-0000-1467-2666)
Institutions
- Qingdao University (CN)
- Yuhuangding Hospital (CN)
- Heze Medical College (CN)
- Shanghai East Hospital (CN)
- Heze Municipal Hospital (CN)
- Yantaishan Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Aging Neuroscience
- Published
- 2025-12-10
- DOI
- https://doi.org/10.3389/fnagi.2025.1679285
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Biogen
- Meso Scale Diagnostics
- BioClinica
- Novartis Pharmaceuticals Corporation
- National Natural Science Foundation of China
- Eisai
- Servier
- H. Lundbeck A/S
- IXICO
- National Institutes of Health
- Genentech
- Canadian Institutes of Health Research